Thomas Higgins
Director of Finance/CFO bij NEUROMETRIX, INC.
Vermogen: 35 904 $ op 31-03-2024
Profiel
Thomas T.
Higgins currently works at NeuroMetrix, Inc., as Chief Financial Officer, Treasurer & Senior VP and Panacos Pharmaceuticals, Inc., as Chief Financial Officer.
Mr. Higgins also formerly worked at Cabot Corp., as Vice President & General Manager-Asia Pacific, V.I.
Technologies, Inc., as Chief Financial Officer & Executive VP-Operations from 1998 to 2005, Caliper Life Sciences, Inc., as Chief Financial Officer & Executive Vice President from 2005 to 2008, and Distrigas of Massachusetts Corp., as President.
Mr. Higgins received his undergraduate degree from Boston University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
NEUROMETRIX, INC.
0.43% | 01-04-2024 | 8 448 ( 0.43% ) | 35 904 $ | 31-03-2024 |
Actieve functies van Thomas Higgins
Bedrijven | Functie | Begin |
---|---|---|
NEUROMETRIX, INC. | Director of Finance/CFO | 10-09-2009 |
PANACOS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Eerdere bekende functies van Thomas Higgins
Bedrijven | Functie | Einde |
---|---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Director of Finance/CFO | 01-03-2008 |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Director of Finance/CFO | 15-08-2005 |
Distrigas of Massachusetts Corp. | President | - |
CABOT CORPORATION | Corporate Officer/Principal | - |
Opleiding van Thomas Higgins
Boston University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CABOT CORPORATION | Process Industries |
NEUROMETRIX, INC. | Health Technology |
PANACOS PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
Distrigas of Massachusetts Corp. |